• Cefixime Tablets
  • Jinying Capsule
  • Yuanqi Boneal Tincture
  • Cihang Capsule
  • Xuesaitong Dispersible Tablets
  • position:home >> list_news

    R&D Framework

    Fangsheng Pharma, whose core competence is new drug R&D since its inception, persists in rejuvenating the company through science and technology. Powerful technological supports, such as multi-platform new drug R&D system, cutting-edge R&D team and sufficient funds and grants for R&D, contribute to the strategy development and plenty of R&D achievements.

    ◆ Multi-platform New Drug R&D System
    Fangsheng Pharma strives to build the multi-platform new drug R&D system, including Hunan Fangsheng Huamei Biopharma Inc., National Center for Doctoral Study, Hunan Cardio & Cerebrovascular Pharmaceutical Engineering Technology Research Center, Hunan Enterprise Technology Center Controlled Release Formulations, Biological Agent Platform and etc., which contributes to the seizing of commanding height in new drug R & D.

    ◆ Cutting-edge R&D Team
    The cutting-edge R&D team guarantees the drug innovation and development. The R&D team in Fangsheng Pharma consists of numbers of returned doctors and professors. The proportion of senior R&D engineers in all staff is up to 10%. While establishing and cultivating internal R & D team, Fangsheng Pharma cooperates with external strength of cutting-edge specialists in domestic and overseas pharmaceutical industries, and science and research institute as well.

    ◆ Sufficient Funds and Grants for R&D
    Continuous investment promises the development of new drugs R&D. We allocate R&D fund according to annual sales revenue by a fixed ratio, which helps to keep a long-term competitive advantage.

    Contact From

    Fangsheng Company

    No.789,Lusong Road

    Yuelu District,Changsha,China

    Business Consultation:+86-0731-88997188

    Complaints Hotline:+86-0731-88908622